In re Sepracor Inc. Securities Litigation

233 F.R.D. 52, 2005 U.S. Dist. LEXIS 34829, 2005 WL 3289250
CourtDistrict Court, D. Massachusetts
DecidedSeptember 8, 2005
DocketNos. 02-CV-12235-MEL, 02-CV-12338-MEL
StatusPublished
Cited by14 cases

This text of 233 F.R.D. 52 (In re Sepracor Inc. Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Sepracor Inc. Securities Litigation, 233 F.R.D. 52, 2005 U.S. Dist. LEXIS 34829, 2005 WL 3289250 (D. Mass. 2005).

Opinion

MEMORANDUM AND ORDER

LASKER, District Judge.

These cases are a consolidation of a number of securities fraud actions brought on behalf of those who invested in Sepracor, Inc. (“Sepracor”). The plaintiffs allege violations of §§ 10(b) and 20(a) of the Securities and Exchange Act of 1934, and of corresponding Securities and Exchange Commission Rule 10b-5. The issue is whether Sepracor made misleading statements about the clinical trial safety record of an antihistamine product named Soltara and its prospects for approval by the Federal Drug Administration (“FDA”). When Soltara’s cardiac side effects and the FDA’s resulting non-approval of Soltara were eventually revealed, the price of Sepracor stock fell approximately 60%, from a closing price of $47.26 per share on March 6, 2002, to a closing price of $19.64 per share on March 7,2002.

The plaintiffs have filed two motions for class certification: (1) a motion by Staro Asset Management, LLC (“Staro”) in the debt purchasers’ action, seeking certification of a class consisting of all persons or entities who purchased Sepracor’s debt securities during the period of May 17, 1999 through March 6, 2002 (the “class period”) and who were damaged thereby; and (2) a motion by Westmont Venture Partners, LLC (‘Westmont”), Leon Atkind (“Atkind”), and Howard Galbut (“Galbut”) in the equity purchasers’ action, seeking certification of a class consisting of all persons or entities who purchased Sepracor common stock or call options, or who sold Sepracor put options, during the class period and who were damaged thereby. The issue for decision is whether the proposed plaintiffs are adequate and typical class representatives.

I. Debt Purchasers’ Action

It is not disputed that the proposed class is so numerous that joinder of all class members is impracticable, or that there are questions of law and fact common to all members [54]*54the class. Moreover, Staro’s claims arise from the same events or course of conduct as do the injuries that form the basis of the class claims and are based on the same legal theory.

The disputed issue for decision is whether Staro is a typical plaintiff who will adequately protect the interests of the class.

Sepracor vehemently challenges Staro’s adequacy and suitability as a class representative for the debt purchaser plaintiffs. In particular, Sepracor questions Staro’s honesty and integrity, in particular its failure to disclose in its filings with the Court that it engaged in hedging transactions in Sepracor stock. I find that these contentions are without merit. Staro filed an action on behalf of a class of bond purchasers and listed all of its bond transactions in its certification, because those were the transactions “in the security that is the subject of the complaint during the class period specified in the complaint.” 15 U.S.C. § 78u-4(a)(2)(A)(iv). See In re Oxford Health Plans Inc. Securities Litigation, 199 F.R.D. 119, 124 (S.D.N.Y.2001)(finding no evidence that the court was misled where named plaintiffs did not list options trades because they were not the subject of the complaint). Moreover, Staro’s settlement of two strict liability short-swing profit eases, one of which was dismissed on summary judgment, does not impinge upon its character. Nothing in the record of this litigation suggests improprieties which might devalue Staro’s adequacy as a class representative.

Sepracor’s contention that Staro suffered no economic loss as a result of Sepracor’s alleged fraud, and is therefore unfit to represent the class, is also without merit. Sepraeor asserts that the net effect of Staro’s convertible arbitrage was that it earned a gain on its class period transactions in Sepracor securities. However, I disagree with Sepracor’s suggested cumulative methodology, which includes offsetting gains in the loss calculation. To the contrary, I find a transaction-based methodology, which allows claims for unprofitable transactions without offsetting that recoverable loss with gains from profitable transactions, to be more consistent with the provisions of the statute and rule. The language of Section 10(b) and Rule 10b-5 is more consistent with a transaction-based methodology than a cumulative one. Both provisions make it illegal for someone to make materially misleading statements “in connection with the purchase or sale of any security.” 15 U.S.C. § 78j(b) (2004); 17 C.F.R. § 240.10b-5 (2004). By using the singular nouns “purchase” or “sale”, Congress and the SEC focus on each transaction individually. Neither the statute nor the Rule authorize any sort of aggregation of purchases or sales that could sanction the cumulative approach.

Argent Classic Convertible Arbitrage v. Rite Aid, 315 F.Supp.2d 666, 680 (E.D.Pa.2004).

Contrary to Sepracor’s contentions, I also find that Staro did rely on the integrity of the market when it purchased Sepracor bonds and engaged in hedging strategies during the class period. “[I]t is hard to imagine that there ever is a buyer or seller who does not rely on market integrity. Who would knowingly roll the dice in a crooked crap game?” Basic, Inc. v. Levinson, 485 U.S. 224, 246-47, 108 S.Ct. 978, 99 L.Ed.2d 194 (1988)(quoting Schlanger v. Four-Phase Systems, Inc., 555 F.Supp. 535, 538 (S.D.N.Y. 1982)). Convertible arbitrage is not inconsistent with reliance on the integrity of the market. Accordingly, the argument that Staro is subject to unique defenses that might rebut the presumption of reliance to the detriment of the class members’ case does not make the grade. Moreover, courts are traditionally reluctant to deny class action status under Rule 23(b)(3) simply because affirmative defenses may be available against individual members. As the Court of Appeals for this circuit has stated: “where common issues otherwise predominated, courts have usually certified Rule 23(b)(3) classes even though individual issues were present in one or more affirmative defenses. After all, Rule 23(b)(3) requires merely that common issues predominate, not that all issues be common to the class.” Smilow v. Southwestern Bell Mobile Systems, Inc., 323 F.3d 32, 39 (1st Cir.2003)(internal citations omitted).

[55]*55I therefore find that Staro has satisfied the requirements of Fed.R.Civ.P. 23(a) and (b), and accordingly the motion for class certification is GRANTED.

II. Equity Purchasers’ Action

A. Proposed Class Representative Leon At-kind

Proposed class representative Atkind’s motion for class certification is DENIED because he fails to meet the typicality and adequacy requirements of Fed.R.Civ.P. 23(a)(3) and (4).

Atkind’s lack of basic knowledge about this case renders him inadequate to serve as a class representative. Greenspan v. Brassler, 78 F.R.D.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Henderson v. Bank of New York Mellon
322 F.R.D. 432 (D. Massachusetts, 2017)
Foley v. Buckley's Great Steaks
2015 DNH 078 (D. New Hampshire, 2015)
Facciola v. Greenberg Traurig LLP
281 F.R.D. 363 (D. Arizona, 2012)
In re Juniper Networks, Inc. Securities Litigation
264 F.R.D. 584 (N.D. California, 2009)
In re Red Hat, Inc. Securities Litigation
261 F.R.D. 83 (E.D. North Carolina, 2009)
In re Credit Suisse-AOL Securities Litigation
253 F.R.D. 17 (D. Massachusetts, 2008)
In re TJX Companies Retail Security Breach Litigation
246 F.R.D. 389 (D. Massachusetts, 2007)
In re Organogenesis Securities Litigation
241 F.R.D. 397 (D. Massachusetts, 2007)
In Re Cigna Corp. Securities Litigation
459 F. Supp. 2d 338 (E.D. Pennsylvania, 2006)
In Re Enron Corp. Securities
529 F. Supp. 2d 644 (S.D. Texas, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
233 F.R.D. 52, 2005 U.S. Dist. LEXIS 34829, 2005 WL 3289250, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-sepracor-inc-securities-litigation-mad-2005.